ELF3 and breast carcinoma: Studies by Brewster et al. (2007) and Peters et al. (2001), from which indirect evidence is available about hormone-receptor status, preclude conclusions about ERT’s role in increasing or decreasing breast cancer recurrence or mortality risk.